Regenerative medicine Contents

Published written evidence

The following written evidence was received and can be viewed on the inquiry publications page of the Committee’s website.

REG numbers are generated by the evidence processing system and so may not be complete.

1Anthony Nolan (REG0021) and (REG0031)

2AstraZeneca (REG0024)

3BioIndustry Association (BIA) (REG0022)

4British Heart Foundation (REG0012)

5Centre for Doctoral Training in Regenerative Medicine (REG0006)

6Centre for Doctoral Training in Regenerative Medicine, University of Manchester (REG0033)

7Charlotte Lozier Institute (REG0023)

8Department of Health (REG0007) and (REG0032)

9Dr Navid Malik (REG0019)

10Dr Paul Lewis (REG0011)

11Genetic Alliance UK (REG0008)

12GSK (REG0027)

13Human Tissue Authority (HTA) (REG0016)

14Innovate UK (REG0013)

15Mr Christopher Roy-Toole (REG0001)

16National Institute for Health and Care Excellence (NICE) (REG0009)

17NHS Blood and Transplant (REG0003)

18Parkinson’s UK (REG0005)

19PHG Foundation (REG0017)

20REGenableMED (REG0004)

21Research Councils UK (REG0028)

22Scottish National Blood Transfusion Service (REG0015)

23The Academy of Medical Sciences (REG0014)

24The Association of the British Pharmaceutical Industry (REG0020)

25The Cell and Gene Therapy Catapult (REG0026)

26The Humanimal Trust (REG0010)

27The Medicines and Healthcare products Regulatory Agency (REG0025)

28University of Bristol (REG0002)

29Wellcome Trust (REG0018)





28 April 2017